Abbott Laboratories stock at EUR 94.93, down 0.66% premarket
Published on 11/20/2026 at 08:29 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWSHealthcare technology remains central
- Abbott develops healthcare technologies for patients and clinicians.
- The company's current portfolio includes the Lingo glucose system.
Abbott Laboratories stock traded at EUR 94.93 on Lang & Schwarz at 08:24 CET on Friday, November 20, 2026, down 0.66 percent from the Xetra close of Thursday, November 19.
Abbott develops healthcare technologies across areas including diagnostics and medical devices. The company highlights its Lingo glucose system among its current offerings, according to Abbott.
U.S. equities are tracked against the S&P 500.
Disclaimer...
en | US0028241000 | ABBOTT LABORATORIES | boerse | 70539047 | bgmi
